Estudo liderado pela oncologista brasileira Adriana Hepner, médica do Instituto do Câncer e ex-Clinical Fellow do Melanoma Institute Australia, Sydney, foi selecionado para poster discussion no #ASCO20 - tinyurl.com/y8d564ee ASCO #ONCONEWSnoASCO #ONCONEWS #MELANOMA

O BR marcou presença no #ASCO20Virtual! Para comemorar o crescimento dos estudos brasileiros na ASCO, um episódio especial do SBOC Review em podcast: Spotify (bit.ly/PodcastSbocSpo…), Apple Music (bit.ly/PodcastSbocApp…) e Soundcloud (bit.ly/SoundCloudSBOC2). 🎧

"For some time, there has been increased awareness in the academic community that all-male panels, or “manels,” are no longer acceptable. For some reason, this has been forgotten in the realm of online meetings. #genderequity connection.asco.org/blogs/covid-19…

Great TED Talks about uncertainty and what really matters to patients. I invite all to appreciate and share Shekinah Elmore, MD, MPH personal and amazing story! tedmed.com/talks/show?id=…

Association Between Universal Masking and SARS-CoV-2 Positivity Among Health Care Workers ja.ma/2OAmR54 vía JAMA part of JAMA Network

Excelent presentation on IO in stage IV #NSCLC with actionable driver mutations at #ASCO20 Educational Program. What is your treatment preference for met EGFRmut after PD on 3rd gen TKI? #LCSM

.Solange Peters on #Covid19 & gender: "Unfortunately, when we meet a crisis, there is a huge risk to exacerbate any inequalities that already exist, including the #gendergap." Join the discussion at the first ever #women4onco Facebook Roundtable (17/9) ow.ly/lzoq50BqeUO

Tuned in #ESMO20 😍☕

Another great data on ICI resistant advanced #melanoma I had the pleasure to collaborate with during my fellowship Melanoma Institute Australia 👀 Mini Oral Session #ESMO20

Great honour to hear Eric J. Small, MD, FASCO talk about a topic that I am so passionate about, inequities in Cancer Care at the Conquer Cancer, the ASCO Foundation 2020 Scientific and Career Development Retreat. Thank you for the invitation! #oncology #CancerResearch

Many kudos to ASCO Conquer Cancer, the ASCO Foundation for the great platform of interaction on the 2020 Scientific and Career Development Retreat. Could definitely do this more often #VirtualEvents #oncology #meetings #clinicalresearch

I am excited to announce that AZ Baselga Scholars Programme is now recruiting candidates. Jose's passion for drug development was the key driver as we shaped this together and we will integrate his lessons to develop the future leaders in drug development astrazeneca.wd3.myworkdayjobs.com/Careers/job/US…

We are making great strides for patients with metastatic breast cancer to help improve outcomes. We must continue raising the bar with more effective therapies. I am proud to be part of the team AstraZeneca that is developing the future of breast cancer care #bcsm

#3: Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis 👩‍⚕️ Anne Zaremba 👉 fro.ntiers.in/F8hB Adriana Hepner Professor Georgina Long AO (Bluesky @gvlongphdmd) @amenzies9 Matteo Carlino Paul Bröckelmann #WomenInScience #WomenInSTEM

Waterfall plots from the nature paper featured as TOP advance in #ACSCancerchat ACS Journal Cancer 👉 The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer Yelena Y. Janjigian MD Darren Cowzer Gil Morgan, MD Suresh S. Ramalingam, MD, FASCO OncoAlert

#wclc2023 : Dato-DxD+durva +-platinum TL04: cohort 2&4. Exciting ORR’s (small n) , no new safety signals as expected for these combos. Honoured to represent EU investigators between US and Asia Ph1 giants. Jessa & Wetenschap LCRC BIOMED_UHasselt Jessa Ziekenhuis

#Targets23 Dr. Alex Spira, M.D. presents early look at RMC-6236, a first-in-class RAS(ON) inhibitor in #KRAS tumors. Safety data very reassuring and example of response in KRAS G12D pancreatic cancer and KRAS G12D NSCLC! Huge unmet need, very exciting - await data at #ESMO23!

Kudos to Professor Georgina Long AO (Bluesky @gvlongphdmd) for receiving the #ESMO23 Women for Oncology Award! So well deserved! An inspiring leader, with exceptional work that extends beyond the melanoma field. I have no words to thank her for the impact she had on my career after working with her at Melanoma Institute Australia

Honoured to have been invitated by ASCO and ESMO - Eur. Oncology to author a chapter on the new edition of ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023. Simultaneous publication during #ESMO23 at JCO Global Oncology and ESMO Open

Our newest collaboration with @amenzies9 Adriana Hepner Matteo Carlino @mcquadeMDLAc @alexshoushtari etc. is online. Insights into acquired resistance to anti-PD-1 based therapy for melanoma. Further treatment with IO-based strategies led to best outcomes. authors.elsevier.com/c/1i7Pz3QE--VL…